Vita Coco CMO trades: 10,000 exercised at $10.178, 10,000 sold

Vita Coco (COCO) reported an insider transaction by its Chief Marketing Officer, Jane Prior.

Accepted by SEC EDGAR 10/31/2025 - 04:59 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Vita Coco (COCO) reported an insider transaction by its Chief Marketing Officer, Jane Prior. On 10/29/2025, she exercised 10,000 stock options at $10.178 per share and, on the same day, sold 10,000 shares at an average price of $45.242. The sales were made pursuant to a Rule 10b5-1 trading plan.

Following these transactions, she beneficially owns 123,666 shares directly. The filing also lists multiple outstanding non‑qualified stock option grants with various exercise prices and expiration dates.

Insider Trade Summary

Exercise and Sale: 10,000 shares ($351K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Prior Jane

Role Chief Marketing Officer

Sold 10,000 shs ($452K)

Approx. gross sale proceeds $452K

Approx. exercise cost $102K

Approx. pre-tax spread $351K

Share of Position Sold 7.5%

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Stock Option (right to buy)	10,000	$0.00	$0.00
Exercise	Common Stock	10,000	$10.178	$102K
Sale	Common Stock	10,000	$45.242	$452K
Holding	Non-Qualified Stock Option (right to buy)	--	--	--
Holding	Non-Qualified Stock Option (right to buy)	--	--	--
Holding	Non-Qualified Stock Option (right to buy)	--	--	--
Holding	Non-Qualified Stock Option (right to buy)	--	--	--
Holding	Non-Qualified Stock Option (right to buy)	--	--	--
Holding	Non-Qualified Stock Option (right to buy)	--	--	--
Holding	Non-Qualified Stock Option (right to buy)	--	--	--

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 179,479 contracts for 155,729 underlying shares (Direct); Common Stock — 123,666 shares (Direct)

Holdings Before and After: Non-Qualified Stock Option (right to buy), 189,479 to 179,479 contracts (Direct); Common Stock, 123,666 to 123,666 shares (Direct)

Other Insiders: 5 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (9)

1. F1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
2. F2. The stock option is fully vested and currently exercisable.
3. F3. The stock option is fully vested and currently exercisable.
4. F4. The stock option is fully vested and currently exercisable.
5. F5. The stock option vests in four equal annual installments beginning on November 27, 2022.
6. F6. The stock option vests in three equal annual installments beginning on August 15, 2025.
7. F7. The stock option vests in four equal annual installments beginning on March 10, 2024.
8. F8. The stock option vests in four equal annual installments beginning on March 4, 2025.
9. F9. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider trade did COCO’s CMO report?

On 10/29/2025, the CMO exercised 10,000 options at $10.178 and sold 10,000 shares at $45.242.

Was the COCO insider sale under a 10b5-1 plan?

Yes. The filing states the sales were made under a Rule 10b5-1 trading plan.

How many COCO shares does the insider hold after the trade?

The reporting person beneficially owns 123,666 shares directly after the reported transactions.

What was the option exercise price for the COCO insider?

The reported option exercise price was $10.178 per share.

At what price were the COCO shares sold by the insider?

Shares were sold at an average price of $45.242.

What is the insider’s role at Vita Coco (COCO)?

The reporting person is an Officer, serving as Chief Marketing Officer.

Does the filing list additional option grants?

Yes. It lists multiple non‑qualified stock options with various exercise prices and expiration dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Prior Jane

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/29/2025		M		10,000	A	$10.178	133,666	D
Common Stock	10/29/2025		S(1)		10,000	D	$45.242	123,666	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178	10/29/2025		M			10,000	(2)	02/10/2030	Common Stock	10,000	$0.0	23,750	D
Non-Qualified Stock Option (right to buy)	$10.178							(3)	12/16/2029	Common Stock	3,675		3,675	D
Non-Qualified Stock Option (right to buy)	$10.178							(4)	01/11/2031	Common Stock	27,300		27,300	D
Non-Qualified Stock Option (right to buy)	$15							(5)	10/21/2031	Common Stock	45,605		45,605	D
Non-Qualified Stock Option (right to buy)	$15.36							(6)	08/15/2032	Common Stock	42,980		42,980	D
Non-Qualified Stock Option (right to buy)	$16.91							(7)	03/10/2033	Common Stock	14,205		14,205	D
Non-Qualified Stock Option (right to buy)	$26.18							(8)	03/04/2034	Common Stock	8,746		8,746	D
Non-Qualified Stock Option (right to buy)	$33.36							(9)	03/04/2035	Common Stock	13,218		13,218	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The stock option is fully vested and currently exercisable.

3. The stock option is fully vested and currently exercisable.

4. The stock option is fully vested and currently exercisable.

5. The stock option vests in four equal annual installments beginning on November 27, 2022.

6. The stock option vests in three equal annual installments beginning on August 15, 2025.

7. The stock option vests in four equal annual installments beginning on March 10, 2024.

8. The stock option vests in four equal annual installments beginning on March 4, 2025.

9. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

	By: Alison Klein, Attorney-in-Fact For: Jane Prior	10/31/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.